Table TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 [see all tables in this series...]

Part (i) Ratio of males to females among new clients entering outpatient treatment

Country		Opioids	Cocaine	Stimulants	Hypnotics and sedatives	Hallucinogens	Volatile substances	Cannabis	Other drugs	Base (known status)
Bulgaria	(1)	3.8						8.0		117
Czech Republic	(2)	2.6	0.0	1.3	3.0	0.0	4.0	3.3	1.0	1029
Denmark	(3)	2.5	3.8	1.9	1.0			4.1	5.3	1111
Germany		3.2	7.0	2.7	0.6	4.5	2.5	6.4	5.8	13842
Ireland	(4)	2.6	4.7	2.8	1.6	0.0	0.5	5.9	0.3	1673
Greece	(5)	6.1	3.3	1.0	1.6	1.0		4.7		1398
Spain	(6)	4.6	5.8	4.1	1.5	12.5	7.5	5.3	2.1	24436
France		3.0	3.6	4.6	0.7	2.3	7.0	7.9	2.7	6983
Italy	(7)	4.7	9.8	3.3	1.7	1.4		10.6	2.3	34836
Cyprus	(8)	12.5	14.5	5.0				5.3		173
Latvia	(9)	3.4		3.3	2.4		29.0	4.9	2.1	437
Hungary	(10)	2.9	2.8	3.0	0.6	2.4	3.0	7.9	1.5	4349
Malta		4.0	6.0	2.2			1.0	7.5		358
Netherlands	(11)	4.4	4.2	2.6	0.9	1.1	5.0	4.0	0.8	5225
Austria	(12)	2.0	3.9	1.8	1.1		0.0	5.5		1494
Portugal		6.3	3.8	1.3	2.0	12.0		5.6	3.3	3716
Slovakia	(13)	2.5	5.0	2.5	0.2		6.5	7.7		364
Finland	(14)	1.5	0.0	1.2	2.2			3.2	2.0	339
Sweden		0.8	2.9	1.2	1.0	5.0	2.0	3.1	4.8	810
United Kingdom		2.7	3.3	1.7	1.1	2.1	1.9	3.3	1.5	44248
Total		3.5	5.6	2.1	1.1	2.0	2.5	5	2.0	4.0
Total base		55073	36216	6716	2573	295	407	43229	2429	146942

Notes:

 Only countries supplying data are reported. 

 (1) No female cases for stimulants, hypnotics and other drugs; no cases for hallucinogens and volatile substances. 

 (2) No female cases for cocaine; no cases for other drugs. 

 (3) No male cases for Volatile substances; no female cases for hallucinogens. 

 (4) No male cases for other drugs; no female cases for hallucinogens. 

 (5) No female cases for other drugs. 

 (6) Data refer to 2004. 

 (7) No female cases for hallucinogens and volatile substances.  

 (8) No female cases for hypnotics and sedatives, hallucinogens. No cases for Volatile substances and other drugs. 

 (9) No female cases hallucinogens. 

 (10) No male cases for cannabis; no female cases for hallucinogens, volatile substances and cocaine. 

 (11) No female cases for hypnotics, hallucinogens and volatile substances; no cases for other drugs. 

 (12) No female cases for stimulants and volatile substances; no cases for hallucinogens. 

 (13) No female cases for cocaine, hallucinogens and other drugs. 

 (14) No male cases for other drugs; no female cases for Volatile substances and no cases for hallucinogens. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2007 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)